Page 44 - JCTR-10-4
P. 44

266                       Biberstein et al. | Journal of Clinical and Translational Research 2024; 10(4): 263-268
        without motion. Therefore, undersurface geometry and surface   the tibial surface had cement coating. However, with the double-
        roughness appear to be important factors in improving fixation at   butter technique, the amount of tray contamination approached
        the implant-cement interface as well. An additional noteworthy   0%  contamination  for  every  implant,  with  a  significant
        finding  from  their  study  was  the  inverse  correlation  between   reduction  noted for each  implant.  Interestingly, there  were
        lipid  contamination  of  the  tibial  tray  and  implant  fixation.   significant differences among the various implants’ surface area
        Specifically, increasing the surface area of the tibial tray that   contamination  suggesting  that  tibial  undersurface  geometries
        was contaminated with lipids correlated with decreased implant   can also affect lipid contamination [22].
        pull-out strength. Therefore, we hypothesize that limiting the   Our  prior  double-butter  study  led  us  to  explore  whether
        amount of contamination of the undersurface of the tibial tray   cement pockets significantly reduce lipid contamination of the
        should theoretically improve implant fixation.         implant-cement interface in this study. Interestingly, the surface
          Additional  factors known to negatively  impact  implant   area of lipid contamination did significantly decrease with the
        fixation  include  component  malalignment,  improper  bone   introduction of cement pockets to the tibial baseplate. The current
        surface preparation and drying, poor cement technique including   tibial implant design shares similar undersurface geometries,
        mixing and handling, potentially high viscosity cements, and   including a peripheral rim and a keel or stem. The peripheral
        smaller cement mantles, as well as other intraoperative surgical   rim is a design feature that allows for cement pressurization into
        technique  errors  [10-14]. In addition,  PMMA, a biologically   bone. As  the  peripheral  rim  is  inserted  into  the  cement,  fluid
        inactive substance that forms through a chemical reaction, has   is trapped under the tibial tray and is then dispersed along the
        numerous potential aberrations that can compromise its strength   implant-cement interface. The undersurface addition of cement
        and stability when used in the clinical setting for TKA [10-12].  pockets did mitigate this dispersion, and in our study, we found
          Billi et al. recently explored a variety of cement techniques,   that the cement pockets were often filled with fluid (Figure 7).
        evaluating  the timing of bone cement application,  as well as   While this study appears to be the first to demonstrate that
        lipid contamination. They noted that early cement application   lipid/fluid contamination is influenced by the addition of cement
        significantly  improved  implant  fixation  and  that  lipid
        contamination led to a significant reduction in implant fixation.
        They demonstrated that cement application to both bone and
        the  implant  with  a  “double-butter”  technique  significantly
        improved implant fixation when lipids were introduced into the
        fixation interface [21].
          We have recently demonstrated a potential mechanism for this
        finding. In a previous study, we evaluated seven contemporary
        tibial  implant  designs and  observed  that  lipid  contamination
        commonly occurred at the implant-cement interface when only

        Table 1. Tibial  baseplate  fluid  contamination  following  simulated
        implantation
        Evaluation                 Fluid contamination (%)
                             Implant A            Implant B    Figure 6. Average tibial baseplate fluid contamination following
        Trial 1                55.315               31.83      simulated implantation between implants A and B (p=0.0265)
        Trial 2                37.025              23.575
        Trial 3                36.125              35.685
        Average*               42.82                30.36
        Implant A has no pockets; implant B has pockets; *p-value of the average is 0.0265.

















        Figure 5. Example of implant A (left) and implant B (right) after   Figure 7. A baseplate trial demonstrating the filling of a cementation
        undergoing trial implantation                          pocket with fluid
                                              DOI: https://doi.org/10.36922/jctr.24.00029
   39   40   41   42   43   44   45   46   47   48